CAIHL read · Jun 9, 2026
Fear of cancer recurrence is a human response, not a flaw
Framework
What CAIHL does
Critical AI Health Literacy (CAIHL) is an analytical lens — Hugo Campos and Liz Salmi's 2025 National Academy of Medicine commentary, "Critical AI Health Literacy as Liberation Technology." It applies Paulo Freire's theory of critical literacy to health AI.
The central question CAIHL asks is whose interests does this AI actually serve? Four dimensions answer it: who is the primary user, where is it hosted, whose interests does it advance, and does it expand or constrain patient agency.
This deep-read separates the four dimensions on a single item from the day's scan, so you can see the specific structural shape of the AI in question — not just the bucket it landed in.
The four dimensions
How this item reads through CAIHL
Primary user
patient
Patients, families, and care partners are the primary users of this AI.
Hosting
public
Hosted for public use (ChatGPT, Claude, consumer apps). Anyone with a device can use it.
Interests
patient-aligned
Interest structure prioritizes patients. Operates on a philanthropic, public-service, or advocacy footing.
Agency
expanding
Expands patient capabilities, supports their questions, increases their ability to act on their own values across and beyond health systems.
Editor's CAIHL read
One-sentence synthesis
Clinician voice reframing emotional response as agency, not pathology; expanding patient-side framing capacity.
In the scan
How this item appeared in the daily scan
Editor's note: When the AI flags the fear, the AI is reading the fear as a metric of disease. The patient is reading the fear as a metric of being alive. Both readings can be true. The clinical workflow has to recognize which one is being measured.
Summary: KevinMD: Clinician essay reframing fear of cancer recurrence as a healthy adaptive response rather than a treatable pathology — directly relevant to the AI symptom-monitoring tools that algorithmically flag the fear.
methodology
Limitations
CAIHL is a lens, not a verdict. The four dimensions are conditions of use — reassess them when a tool's business model, deployment context, or patient behavior changes. See the NAM commentary for the full framework.